Virginia Retirement Systems’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Buy
17,250
+1,200
+7% +$72.7K 0.01% 706
2026
Q1
$890K Buy
16,050
+10,200
+174% +$549K 0.01% 623
2025
Q4
$284K Buy
+5,850
New +$228K ﹤0.01% 859
2023
Q1
Sell
-10,800
Closed -$335K 1042
2022
Q4
$335K Buy
10,800
+100
+0.9% +$2.82K ﹤0.01% 941
2022
Q3
$273K Buy
+10,700
New +$251K ﹤0.01% 976
2022
Q1
$364K Sell
14,700
-4,600
-24% -$139K ﹤0.01% 934
2021
Q4
$671K Sell
19,300
-9,100
-32% -$289K ﹤0.01% 771
2021
Q3
$770K Sell
28,400
-100
-0.4% -$2.54K 0.01% 687
2021
Q2
$739K Buy
28,500
+1,300
+5% +$31.2K 0.01% 744
2021
Q1
$586K Sell
27,200
-7,700
-22% -$194K 0.01% 840
2020
Q4
$750K Buy
34,900
+12,100
+53% +$294K 0.01% 704
2020
Q3
$336K Buy
22,800
+100
+0.4% +$1.8K ﹤0.01% 894
2020
Q2
$507K Buy
22,700
+5,700
+34% +$104K 0.01% 791
2020
Q1
$240K Buy
17,000
+2,100
+14% +$31.8K ﹤0.01% 989
2019
Q4
$242K Buy
+14,900
New +$352K ﹤0.01% 1072

Other funds holding ANAB

Virginia Retirement Systems's ANAB Position: Q2 2026 in Review

Virginia Retirement Systems increased its AnaptysBio (ANAB) stake by 7.5% in Q2 2026, buying an estimated $72.7K and bringing the position to 17,250 shares worth $1.16M. The position accounts for 0.01% of the portfolio, ranked #706.

Virginia Retirement Systems first reported a position in ANAB in Q4 2019 and has held it in 15 quarters since. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Virginia Retirement Systems held 17,250 shares of AnaptysBio worth $1.16M as of Q2 2026.
  • Virginia Retirement Systems bought 1,200 AnaptysBio shares in Q2 2026, an estimated $72.7K.
  • AnaptysBio made up 0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #706 holding.
  • Virginia Retirement Systems first reported a position in AnaptysBio in Q4 2019 and has held it in 15 quarters since.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.